SCHEMBL1664239

SCHEMBL1664239

COc1ccc2oc(-c3ccc(C#Cc4ccccc4)cc3)c(O)c(=O)c2c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 2/20 0.73
KDM4E B2RXH2 9/20 0.65
CYP3A4 P08684 6/20 0.65
HSD17B10 Q99714 6/20 0.65
ALDH1A1 P00352 5/20 0.65
CSNK2A2 P19784 2/20 0.64
CSNK2B P67870 2/20 0.64
CSNK2A1 P68400 2/20 0.64
MAPT P10636 8/20 0.61
TP53 P04637 5/20 0.61
HPGD P15428 5/20 0.61
MEN1 O00255 4/20 0.61
KMT2A Q03164 4/20 0.61
CASP1 P29466 2/20 0.61
CASP7 P55210 2/20 0.61
TSHR P16473 4/20 0.60
CYP2C9 P11712 3/20 0.60
CYP2D6 P10635 2/20 0.60
CYP2C19 P33261 2/20 0.60
TDP1 Q9NUW8 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2121813 0.89 KDM4E (0.74) ADORA3KDM4ECYP3A4HSD17B10ALDH1A1
SCHEMBL15676583 0.89 KDM4E (0.74) ADORA3KDM4ECYP3A4HSD17B10ALDH1A1
SCHEMBL4650608 0.87 CSNK2A2 (0.82) ADORA3KDM4ECYP3A4HSD17B10ALDH1A1
SCHEMBL27325970 0.84 KDM4E (0.62) ADORA3KDM4ECYP3A4HSD17B10ALDH1A1
SCHEMBL7124716 0.84 CSNK2A2 (0.74) ADORA3KDM4ECYP3A4HSD17B10ALDH1A1
SCHEMBL5138118 0.81 MAPT (0.84) ADORA3KDM4ECYP3A4HSD17B10ALDH1A1
SCHEMBL7659274 0.80 ADORA3 (0.81) ADORA3KDM4ECYP3A4HSD17B10ALDH1A1
SCHEMBL15676588 0.79 KDM4E (0.85) ADORA3KDM4ECYP3A4HSD17B10ALDH1A1
SCHEMBL4650060 0.79 KDM4E (0.85) ADORA3KDM4ECYP3A4HSD17B10ALDH1A1
SCHEMBL7606772 0.79 CSNK2A2 (0.67) ADORA3KDM4ECYP3A4HSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2311806-A2 Dihydropyridine-, pyridine-, benzopyranone- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists The United States of America, Represented by the Secretary, Department of Health and Human Services (US) 2011-04-20 EP disclosed
US-6066642-A FOR SELECTIVELY BLOCKING THE A3 ADENOSINE RECEPTOR OF A MAMMAL THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2000-05-23 US disclosed